Track the SciSparc Ltd. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.8m. The latest transaction was reported on 22 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: SMITH JAMES EDMOND. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
SciSparc Ltd. is a company focused on developing treatments for neurological diseases. It is listed on the NASDAQ under the ticker SPRC.